Share this post on:

Product Name :
Vosoritide

Search keywords :
Arylsulfatase

drugId :
null

Target Vo:
Atrial natriuretic peptide receptor type B

Target Vo Short Name :
ANPRB

Moa_Name:
Atrial natriuretic peptide receptor type B agonists

First Approval Country :
EU

First Approval Date Filter:
2021

Origin Company_Name :
Biomarin Pharmaceutical Inc

Active Company_Name :
Biomarin International Ltd

Active Indication_Name:
Achondroplasia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Olokizumab Immunology/Inflammation
STAT5b Rabbit mAb Purity
Ubiquitin-like modifier-activating enzyme 1 Antibody: Ubiquitin-like modifier-activating enzyme 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 118 kDa, targeting to Ubiquitin-like modifier-activating enzyme 1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Betaine hydrochloride